Foscarnet as inpatient prophylaxis only is insufficient to prevent cytomegalovirus infection after marrow transplantation.
B
B
Lönnqvist
J
J
Aschan
O
O
Ringdén
D016026:Bone Marrow Transplantation; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D017245:Foscarnet / Q000627:therapeutic use*; D006801:Humans; D007297:Inpatients; D013997:Time Factors; D014184:Transplantation, Homologous
D017245:Foscarnet